Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Lymphoma

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 13 articles: HTML format

Single Articles

December 2025
1. GUI A, Yan Y, Jiang S, Chen F, et al
   USP1-TRAF2 axis-regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma.
   Proc Natl Acad Sci U S A. 2025;122:e2504195122.
   PubMed     Abstract available
   
   
   November 2025
2. LIN M, Li G, Tang X, Li R, et al
   A viral Cyclin D homolog protein hijacks the metabolic stress sensor SESN2 to promote primary effusion lymphoma growth.
   Proc Natl Acad Sci U S A. 2025;122:e2520925122.
   PubMed     Abstract available
   
   
   August 2025
3. HUANG Y, Lin H, Shi J, Chen Y, et al
   Serum metabolic patterns reveal the diagnostic and prognostic role of alanine abnormality in ocular adnexal lymphoma.
   Proc Natl Acad Sci U S A. 2025;122:e2506345122.
   PubMed     Abstract available
   
   
   June 2025
4. ZHANG N, Seo JW, Robinson E, Rivera-Rodriguez A, et al
   Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging.
   Proc Natl Acad Sci U S A. 2025;122:e2504950122.
   PubMed     Abstract available
   
   
   April 2025
5. TILI E, Commisso TL, Balatti V, Michaille JJ, et al
   miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas.
   Proc Natl Acad Sci U S A. 2025;122:e2422615122.
   PubMed     Abstract available
   
   
   December 2024
6. CERIBELLI M, Tosto FA, Zhang X, Melani CJ, et al
   Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity.
   Proc Natl Acad Sci U S A. 2024;121:e2413372121.
   PubMed     Abstract available
   
   
   July 2024
7. ZHONG X, Moresco JJ, SoRelle JA, Song R, et al
   Disruption of the ZFP574-THAP12 complex suppresses B cell malignancies in mice.
   Proc Natl Acad Sci U S A. 2024;121:e2409232121.
   PubMed     Abstract available
   
   
   April 2024
8. LI MY, Chong LC, Duns G, Lytle A, et al
   TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma.
   Proc Natl Acad Sci U S A. 2024;121:e2320421121.
   PubMed     Abstract available
   
   
   
9. MAROUI MA, Odongo GA, Mundo L, Manara F, et al
   Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
   Proc Natl Acad Sci U S A. 2024;121:e2314426121.
   PubMed     Abstract available
   
   
   
10. KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al
    Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
    Proc Natl Acad Sci U S A. 2024;121:e2316447121.
    PubMed     Abstract available
    
    
    March 2024
11. MA J, Al Moussawi K, Lou H, Chan HF, et al
    Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment.
    Proc Natl Acad Sci U S A. 2024;121:e2309957121.
    PubMed     Abstract available
    
    
    January 2024
12. 
    Correction for Scuoppo et al., Repurposing dasatinib for diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2024;121:e2321988121.
    PubMed    
    
    
    December 2023
13. JUILLAND M, Alouche N, Ubezzi I, Gonzalez M, et al
    Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
    Proc Natl Acad Sci U S A. 2023;120:e2301155120.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.